TY - JOUR
T1 - GUÍA DE PRÁCTICA CLÍNICA PARA EL MANEJO DE COVID-19 EN PEDIATRÍA EN EL SEGURO SOCIAL DEL PERÚ (ESSALUD)
T2 - SÍNTESIS DE EVIDENCIA Y RECOMENDACIONES
AU - Juan, Manuel Ortiz Chicchon
AU - Chávez-Rimache, Lesly
AU - Vigil, Matilde Emperatriz Estupiñán
AU - Alvarado-Gamarra, Giancarlo
AU - Abanto, Manuel Eduardo Munaico
AU - Ruíz, Renato DÍaz
AU - Alegre, Susana Villegas
AU - Vásquez, Darwin Mauricio Silva
AU - Vílchez, Medalit Luna
AU - Seminario, Paulo Delgado
AU - Salvador-Salvador, Stefany
AU - Carrera-Acosta, Lourdes
AU - Taype-Rondan, Alvaro
AU - Santos-Sánchez, Vladimir Ernesto
AU - Atamari-Anahui, Noé
N1 - Publisher Copyright:
© 2024 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.
PY - 2024
Y1 - 2024
N2 - Introduction: Since the beginning of the COVID-19 pandemic, different drugs and medications have been used for the prevention and treatment of COVID-19 infection. Likewise, various investigations have been developed that evaluate the effectiveness and safety of these interventions, which have concluded that they generate more harm than benefit in patient management. For this reason, it is relevant to standardize the interventions that have proven to be effective and safe in the management of pediatric patients with COVID-19. Objective: Provide evidence-based clinical recommendations for the management of COVID-19 in pediatrics. Methods: A guideline development group (GEG) was formed that included pediatric specialists and methodologists. The GEG formulated 11 clinical questions to be answered by this CPG (Table 1). For its preparation, the GEG decided to carry out a rapid adaptation of the Guide for the care of critically ill adult patients with COVID-19 in the Americas of the Pan American Health Organization (PAHO). To formulate the recommendations, the evidence frameworks for decision (EtD) of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology were developed. Results: This CPG addressed 11 clinical questions on management. Based on these questions, 21 recommendations were formulated (13 strong and 8 conditional), 19 good clinical practices (GCP), and 1 flow chart. Conclusion: This article summarizes the methodology and conclusions based on evidence of the CPG for the management of COVID-19 in pediatrics in EsSalud.
AB - Introduction: Since the beginning of the COVID-19 pandemic, different drugs and medications have been used for the prevention and treatment of COVID-19 infection. Likewise, various investigations have been developed that evaluate the effectiveness and safety of these interventions, which have concluded that they generate more harm than benefit in patient management. For this reason, it is relevant to standardize the interventions that have proven to be effective and safe in the management of pediatric patients with COVID-19. Objective: Provide evidence-based clinical recommendations for the management of COVID-19 in pediatrics. Methods: A guideline development group (GEG) was formed that included pediatric specialists and methodologists. The GEG formulated 11 clinical questions to be answered by this CPG (Table 1). For its preparation, the GEG decided to carry out a rapid adaptation of the Guide for the care of critically ill adult patients with COVID-19 in the Americas of the Pan American Health Organization (PAHO). To formulate the recommendations, the evidence frameworks for decision (EtD) of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology were developed. Results: This CPG addressed 11 clinical questions on management. Based on these questions, 21 recommendations were formulated (13 strong and 8 conditional), 19 good clinical practices (GCP), and 1 flow chart. Conclusion: This article summarizes the methodology and conclusions based on evidence of the CPG for the management of COVID-19 in pediatrics in EsSalud.
KW - Clinical Practice Guideline
KW - COVID-19
KW - Evidence-Based Medicine
KW - GRADE Approach (source: DeCS bireme)
UR - http://www.scopus.com/inward/record.url?scp=85211369436&partnerID=8YFLogxK
U2 - 10.35434/rcmhnaaa.2024.173.2391
DO - 10.35434/rcmhnaaa.2024.173.2391
M3 - Artículo
AN - SCOPUS:85211369436
SN - 2225-5109
VL - 17
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 3
ER -